{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T03:30:38Z","timestamp":1775187038824,"version":"3.50.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"am","delay-in-days":354,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001463","name":"American Society of Nephrology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001463","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["K24AG073615"],"award-info":[{"award-number":["K24AG073615"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01 HX002763"],"award-info":[{"award-number":["I01 HX002763"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1053\/j.ajkd.2025.02.603","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T09:55:59Z","timestamp":1744106159000},"page":"202-211.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Safety and Effectiveness of Nirmatrelvir-Ritonavir in Patients With Advanced Kidney Dysfunction and COVID-19"],"prefix":"10.1053","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-3809-0801","authenticated-orcid":false,"given":"Marimar","family":"Contreras Nieves","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuchi","family":"Anand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I-Chun","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Geldsetzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrica","family":"Fung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manjula Kurella","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria E.","family":"Montez-Rath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1053\/j.ajkd.2025.02.603_bib3","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2215\/CJN.13820820","article-title":"Outcomes of COVID-19 in CKD patients: a multicenter electronic medical record cohort study","volume":"16","author":"Pakhchanian","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"issue":"15","key":"10.1053\/j.ajkd.2025.02.603_bib4","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa2118542","article-title":"Oral nirmatrelvir for high-risk, nonhospitalized adults with COVID-19","volume":"386","author":"Hammond","year":"2022","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1053\/j.ajkd.2025.02.603_bib7","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.2215\/CJN.05270522","article-title":"Prescribing nirmatrelvir\/ritonavir for COVID-19 in advanced CKD","volume":"17","author":"Hiremath","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"10.1053\/j.ajkd.2025.02.603_bib8","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1093\/cid\/ciad371","article-title":"Safety profile and clinical and virological outcomes of nirmatrelvir-ritonavir treatment in patients with advanced chronic kidney disease and coronavirus disease 2019","volume":"77","author":"Chan","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"25","key":"10.1053\/j.ajkd.2025.02.603_bib10","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"key":"10.1053\/j.ajkd.2025.02.603_bib11","series-title":"Categorical Data Analysis","author":"Agresti","year":"2013"},{"key":"10.1053\/j.ajkd.2025.02.603_bib12","series-title":"Stata 18 Base Reference Manual","year":"2023"},{"key":"10.1053\/j.ajkd.2025.02.603_bib13","series-title":"Stata Statistical Software: Release 18","year":"2023"},{"issue":"6","key":"10.1053\/j.ajkd.2025.02.603_bib14","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1053\/j.ajkd.2021.03.019","article-title":"Risk of potentially inappropriate medications in adults with CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study","volume":"78","author":"Hall","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"29","key":"10.1053\/j.ajkd.2025.02.603_bib15","doi-asserted-by":"crossref","DOI":"10.1503\/cmaj.146430-l","article-title":"Renalism","volume":"194","author":"Hiremath","year":"2022","journal-title":"CMAJ"},{"issue":"10","key":"10.1053\/j.ajkd.2025.02.603_bib16","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1681\/ASN.2020060877","article-title":"The exclusion of patients with CKD in prospectively registered interventional trials for COVID-19: a rapid review of international registry data","volume":"31","author":"Major","year":"2020","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2025.02.603_bib17","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ekir.2020.10.010","article-title":"Phase-3 randomized controlled trials on exclusion of participants with kidney disease in COVID-19","volume":"6","author":"Chewcharat","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"7","key":"10.1053\/j.ajkd.2025.02.603_bib18","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1681\/ASN.2020050589","article-title":"Remdesivir in patients with acute or chronic kidney disease and COVID-19","volume":"31","author":"Adamsick","year":"2020","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2025.02.603_bib20","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2215\/CJN.0000000000000107","article-title":"Early experience with modified dose nirmatrelvir\/ritonavir in dialysis patients with coronavirus disease 2019","volume":"18","author":"Hiremath","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2025.02.603_bib21","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/cpt.2688","article-title":"Pharmacokinetics of oral nirmatrelvir\/ritonavir, a protease inhibitor for treatment of COVID-19, in subjects with renal impairment","volume":"112","author":"Toussi","year":"2022","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"10.1053\/j.ajkd.2025.02.603_bib23","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3390\/v15040976","article-title":"The antiviral effect of nirmatrelvir\/ritonavir during COVID-19 pandemic real-world data","volume":"15","author":"Petrakis","year":"2023","journal-title":"Viruses"},{"issue":"1","key":"10.1053\/j.ajkd.2025.02.603_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.107020","article-title":"Effect of pre-hospitalization use of oral antiviral agents on reducing critical illness and mortality for patients with COVID-19 pneumonia","volume":"63","author":"Yii","year":"2024","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"10.1053\/j.ajkd.2025.02.603_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.2473","article-title":"Efficacy and safety of paxlovid (nirmatrelvir\/ritonavir) in the treatment of COVID-19: an updated meta-analysis and trial sequential analysis","volume":"33","author":"Tian","year":"2023","journal-title":"Rev Med Virol"},{"issue":"1","key":"10.1053\/j.ajkd.2025.02.603_bib26","doi-asserted-by":"crossref","first-page":"7832","DOI":"10.1038\/s41598-023-35068-w","article-title":"Association of molnupiravir and nirmatrelvir-ritonavir with reduced mortality and sepsis in hospitalized omicron patients: a territory-wide study","volume":"13","author":"Wai","year":"2023","journal-title":"Sci Rep"},{"issue":"suppl 2","key":"10.1053\/j.ajkd.2025.02.603_bib27","article-title":"786. Effect of nirmatrelvir\/ritonavir versus placebo on COVID-19\u2013related hospitalizations and other medical visits","volume":"9","author":"Hammond","year":"2022","journal-title":"Open Forum Infect Dis"},{"issue":"7","key":"10.1053\/j.ajkd.2025.02.603_bib28","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2215\/CJN.0000000000000186","article-title":"Management and outcome of COVID-19 infection using nirmatrelvir\/ritonavir in kidney transplant patients","volume":"18","author":"Gigu\u00e8re","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2025.02.603_bib29","author":"Madhav"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638625007772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638625007772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T08:32:51Z","timestamp":1753086771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638625007772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0272638625007772"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2025.02.603","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and Effectiveness of Nirmatrelvir-Ritonavir in Patients With Advanced Kidney Dysfunction and COVID-19","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2025.02.603","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the National Kidney Foundation, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}